• No results found

University of Groningen Biomarkers in stable and acute exacerbations of COPD Prins, Hendrik J

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Biomarkers in stable and acute exacerbations of COPD Prins, Hendrik J"

Copied!
5
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Biomarkers in stable and acute exacerbations of COPD

Prins, Hendrik J

DOI:

10.33612/diss.136484081

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Prins, H. J. (2020). Biomarkers in stable and acute exacerbations of COPD. University of Groningen. https://doi.org/10.33612/diss.136484081

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

12

(3)
(4)

Chapter 12

(5)

12

Publications

171

List of publications

Rommers GM, Prins HJ, Interdisciplinair opleiden: AIOS leren van elkaar. Nederlands tijdschrift voor revalidatiegeneeskunde June 2020

Prins HJ, Van der Werf TS, Boersma WG. Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? European Respiratory Journal October 2019

Prins HJ, Duijkers R, Van der Valk P, Schoorl M, Daniels JMA, Van der Werf TS, Boersma WG. CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions. European Respiratory Journal May 2019

Prins HJ, Duijkers R, Lutter R, Daniels JMA, Van der Valk P, Schoorl M, Kerstjens HA, Van der werf TS, Boersma WG. Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD. Respiratory Medicine October 2017

Rafiq R, Prins HJ, Boersma WG, Daniels JMA, Den Heijer M, Lips P, De Jongh RT. Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a Pilot trial. International Journal of Obstructive pulmonary disease August 2017

Prins HJ, Daniels JMA, Lindeman JH, Lutter R, Boersma WG. Effects of doxycycline on local and systemic inflammation in stable COPD patients, a randomized clinical trial. Respiratory Medicine January 2016

Book Chapter

Prins HJ. Van krokodillenmanagement naar bezield persoonlijk leiderschap. In: De ziel van Werk, inspiratieboek voor gezondheid, zingeving, bezieling en werk. Kampen, The Netherlands. Ten Have 2009.

Referenties

GERELATEERDE DOCUMENTEN

Biomarkers in stable and acute exacerbations of COPD Prins, Hendrik

Chronic obstructive pulmonary disease (COPD) is defined as ‘a common, preventable and treatable disease that is characterised by persistent respiratory symptoms and airflow

14 We therefore hypothesized that CRP-guided antibiotic therapy may lead to a reduction of antibiotic therapy within 24 hours after admission compared to patient reported

First, in our study population, there was no significant difference in failure rates at days 10 and 30 between the CRP and GOLD group - which strongly argues against their point

This study demonstrates two important new findings related to blood eosinophilia, which was present in 19% of patients with an AECOPD at presentation to the hospital

However in this study we were not able to show effect of a 3 week course of doxycycline on sputum MPO, or on any of the other sputum and serum inflammatory markers as well as

However it has recently been reported that patients with AECOPD who have high bacterial sputum load during AECOPD had a significant decrease in blood eosinophilic count compared

In chapter 6 we present the results of an exploratory double blind randomized controlled trial investigating the effect of a 3-week course of doxycycline on sputum and